Literature DB >> 16501737

[Tuberculin skin test to estimate the prevalence of Mycobacterium tuberculosis infection in indigenous populations in the Americas: a literature review].

Paulo Cesar Basta1, Luiz Antonio Bastos Camacho.   

Abstract

A systematic review was conducted on articles reporting tuberculin surveys to estimate the prevalence and annual risk of tuberculosis infection (ARI) in indigenous peoples of the Americas. MEDLINE and LILACS databases were searched using the following combination of descriptors: "tuberculosis", "South American Indians", "North American Indians", "tuberculin skin test", "PPD", "risk assessment", and "BCG vaccine". Longitudinal and cross-sectional studies published from 1974 to 2004 were selected if the outcome was Mycobacterium tuberculosis infection defined by tuberculin reactions > 5mm or > 10mm. From a total of 54 candidate studies generated with the descriptors, 16 were selected for review. Altogether, they comprised 13,186 individuals, 50% of whom were below 15 years of age. Estimates of prevalence of tuberculosis infection ranged from 0% to 93.4%, whereas the ARI ranged from 0% to 35.4%. Analysis of heterogeneity in environmental conditions and methods of infection assessment in the studies showed that the tuberculin test is useful for clinical decisions (e.g., to initiate chemoprophylaxis), and that tuberculin surveys are useful to assess tuberculosis control measures among indigenous peoples.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16501737     DOI: 10.1590/s0102-311x2006000200002

Source DB:  PubMed          Journal:  Cad Saude Publica        ISSN: 0102-311X            Impact factor:   1.632


  2 in total

1.  Impact of latent infection treatment in indigenous populations.

Authors:  Lucia Suemi Yuhara; Flávia Patussi Correia Sacchi; Julio Croda
Journal:  PLoS One       Date:  2013-07-31       Impact factor: 3.240

2.  Chronic symptoms and pulmonary dysfunction in post-tuberculosis Brazilian patients.

Authors:  Simone de Sousa Elias Nihues; Eliane Viana Mancuzo; Nara Sulmonetti; Flávia Patussi Correia Sacchi; Vanessa de Souza Viana; Eduardo Martins Netto; Silvana Spindola Miranda; Julio Croda
Journal:  Braz J Infect Dis       Date:  2015-08-05       Impact factor: 3.257

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.